scispace - formally typeset
Search or ask a question

Showing papers by "Gabriel Lopez-Berestein published in 2016"

Journal Article•DOI•
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2

[...]

Roxana S. Redis1, Luz E. Vela2, Weiqin Lu1, Juliana Ferreira de Oliveira, Cristina Ivan1, Cristian Rodriguez-Aguayo1, Douglas Adamoski, Barbara Pasculli1, Ayumu Taguchi1, Yunyun Chen1, Agustín F. Fernández3, Luis Valledor3, Katrien Van Roosbroeck1, Samuel Chang1, Maitri Y. Shah1, Garrett Kinnebrew4, Leng Han5, Yaser Atlasi6, Lawrence H. Cheung1, Gilbert Yuanjay Huang1, Paloma Monroig1, Marc S. Ramirez1, Tina Catela Ivković1, Long Van2, Hui Ling1, Roberta Gafà7, Sanja Kapitanović, Giovanni Lanza7, James A. Bankson1, Peng Huang1, Stephan Y. Lai1, Robert C. Bast1, Michael G. Rosenblum1, Milan Radovich4, Mircea Ivan4, Geoffrey Bartholomeusz1, Han Liang1, Mario F. Fraga8, William R. Widger2, Samir M. Hanash1, Ioana Berindan-Neagoe9, Ioana Berindan-Neagoe10, Ioana Berindan-Neagoe1, Gabriel Lopez-Berestein1, Andre Luis Berteli Ambrosio, Sandra Martha Gomes Dias, George A. Calin1 •
University of Texas MD Anderson Cancer Center1, University of Houston2, University of Oviedo3, Indiana University4, University of Texas Health Science Center at Houston5, Erasmus University Rotterdam6, University of Ferrara7, Spanish National Research Council8, Iuliu Hațieganu University of Medicine and Pharmacy9, Babeș-Bolyai University10
18 Feb 2016-Molecular Cell
TL;DR: The CCAT2 interaction with the CFIm complex fine-tunes the alternative splicing of Glutaminase (GLS) by selecting the poly(A) site in intron 14 of the precursor mRNA.

145 citations

Patent•
Dual assembly nanoparticles

[...]

Burcu Aslan1, Gabriel Lopez-Berestein1, Anil K. Sood1•
University of Texas System1
23 Jun 2016
TL;DR: In this article, the delivery of a therapeutic agent or a diagnostic agent to a subject that include a chitosan and a polyphosphate, wherein the CHITOSAN nanoparticles are coated with polylactic acid was discussed.
Abstract: Disclosed are nanoparticles for the delivery of a therapeutic agent or a diagnostic agent to a subject that include a chitosan and a polyphosphate, wherein the chitosan nanoparticles are coated with polylactic acid. Methods of delivering a therapeutic agent or a diagnostic agent to a subject for the treatment or prevention of a disease are also disclosed. For example, the treatment of ovarian cancer in a subject by inhibiting the expression of ZNF034 is disclosed.

1 citations